Publicacións nas que colabora con María Rosario Luquin Piudo (27)

2009

  1. Enfermedad de Parkinson y trastornos del sueño: clínica y alteraciones morfologicas

    Medicina del sueño: enfoque multidisciplinario (Editorial Médica Panamericana), pp. 145-157

  2. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication

    Journal of Neurochemistry, Vol. 110, Núm. 4, pp. 1321-1329

  3. Neuroprotección en la enfermedad de parkinson: Análisis a través de la metodología de informadores clave

    Neurologia, Vol. 24, Núm. 2, pp. 113-124

1996

  1. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum

    Neurology, Vol. 47, Núm. 1, pp. 219-224

  2. Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes

    Neurology, Vol. 46, Núm. 3, pp. 802-809

  3. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease

    Parkinson's disease

  4. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.

    Advances in neurology, Vol. 69, pp. 209-216

  5. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis

    Brain, Vol. 119, Núm. 5, pp. 1717-1727

1995

  1. Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA

    European Journal of Neuroscience, Vol. 7, Núm. 6, pp. 1199-1209

  2. Effects of l-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

    Neuroscience, Vol. 68, Núm. 4, pp. 1189-1198

  3. Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain

    Experimental Neurology, Vol. 131, Núm. 1, pp. 108-113

1994

  1. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP–intoxicated monkeys: Effect of levodopa and GM1 ganglioside therapy

    Annals of Neurology, Vol. 36, Núm. 2, pp. 206-214

  2. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration

    Neuroscience Letters, Vol. 175, Núm. 1-2, pp. 121-125

  3. Subthalamotomy improves MPTP-lnduced parkinsonism in monkeys

    Stereotactic and Functional Neurosurgery, Vol. 62, Núm. 1-4, pp. 98-102

1993

  1. Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys

    Journal of the Neurological Sciences, Vol. 114, Núm. 1, pp. 40-44

  2. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

    Neuroscience, Vol. 56, Núm. 2, pp. 499-511

  3. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys

    Neuroscience, Vol. 56, Núm. 4, pp. 965-972

  4. Gangliosides and parkinsonism

    Neurology, Vol. 43, Núm. 10, pp. 2132-2134

  5. Origin of chorea‐ballism and multisystem degeneration: Pathophysiological implications

    Movement Disorders, Vol. 8, Núm. 1, pp. 123-124

  6. The subthalamic nucleus: A possible target for stereotaxic surgery in parkinson's disease

    Movement Disorders, Vol. 8, Núm. 4, pp. 421-429